Form 4: Hinge Health CFO Sells Shares Under 10b5-1 Plan

Hinge Health's Chief Financial Officer, James Budge, reported a sale of Class A Common Stock executed under a pre-arranged trading plan.

Summary

• James Budge, Chief Financial Officer of Hinge Health, Inc., reported a transaction involving Class A Common Stock.
• The transaction occurred on May 20, 2026, and involved the sale of 781 shares.
• This sale was executed as part of a Rule 10b5-1 trading plan established on June 12, 2025.
• Following the transaction, Mr. Budge beneficially owns 451,293 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the sale was conducted under a pre-established 10b5-1 plan, indicating a planned transaction rather than a reaction to current company performance.

Negatives

• The Chief Financial Officer sold a portion of their holdings.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that insider sales, particularly when executed under a Rule 10b5-1 plan, are common and often reflect pre-planned diversification or liquidity needs rather than a negative view of the company's prospects. However, significant sales by key executives warrant monitoring.

Stakeholder Impact

• Shareholders: The sale by a key executive may be perceived negatively, though the 10b5-1 plan mitigates this concern. The remaining beneficial ownership indicates continued significant stake.

Key Dates

Keywords

Hinge Health, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Class A Common Stock, CFO